You are here: Industry Insights > immune

News List

ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Novel Immune Check Point Bispecifics for $220 Million en-cphi.cn
March 01, 2019
WuXi Biologics and ABL Bio Corporation announced the expansion of their strategic partnership for novel bispecific antibodies and immune-oncology program.
J&J touts new immune response data for HIV vaccine fiercepharma
December 04, 2018
Johnson & Johnson has already advanced a “mosaic” HIV vaccine candidate into efficacy testing in five southern African countries...
Marmosets viable in vivo models for developing immune-based therapies biospectrumasia
November 27, 2018
Due to close physiological replication of infectious disease pathology in humans and lower husbandry costs compared to traditional models of larger primates.
Higher mutational burdens in tumours linked to greater immunotherapy success, study finds pharmafile
December 22, 2017
New research from the Johns Hopkins Kimmel Cancer Center and its Bloomberg-Kimmel Cancer Institute for Cancer Immunotherapy has indicated that the mutational burden can provide a strong indicator as to whether a cancer will respond to checkpoint inhibito
Scientists of Osaka University find that one identical twin is susceptible to autoimmune diseases biospectrumasia
December 18, 2017
The study demonstrates the complexity in diagnosing metabolic diseases like thyroid disorders.
A novel immuno-oncology approach to treating a rare childhood brain cancer fiercebiotech
December 05, 2017
rare type of childhood brain tumor called diffuse intrinsic pontine glioma (DIPG) has a distinct characteristic that may prove to be its undoing—a misshapen protein displayed prominently on the surfaces of its cells.
Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases b3cnewswire
November 24, 2017
Sanofi's research collaboration achieved a third milestone triggering undisclosed milestone payments
New initiative to accelerate development of universal influenza vaccines europeanpharmaceuticalreview
October 30, 2017
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines…
Breakthrough study could revolutionise MS treatment pharmafile
October 16, 2017
The results of a study from the University of California, San Francisco will be welcomed with a certain excitement from all quarters, given that it seems to show the repair of myelin damaged by multiple sclerosis
Janssen deal gives new kid in town Provention two immune candidates fiercebiotech
September 22, 2017
Right on the heels of a $28 million seed financing, Provention Bio has snapped up two inflammatory bowel disease candidates from Janssen that should make it a double clinical-stage biotech next year.

Previous page 1 2 3 Next page